Nov 6 (Reuters) – Moderna lifted its full-year revenue forecast on Friday, after strong international demand for its COVID-19 vaccine and payments from partnerships helped the biotech swing to profit
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Nov 6 (Reuters) - TKMS AG & CO KGAA: * TKMS AND CFF FLUID CONTROL…
By Milana Vinn NEW YORK, Nov 6 (Reuters) - US networking software and equipment maker…
By Milana Vinn NEW YORK, Nov 6 (Reuters) - US networking software and equipment maker…
COLOMBIA MARKETED GAS PRODUCTION DOWN 13.39% YEAR-OVER-YEAR IN SEPTEMBER TO 705 MILLION CUBIC FEET PER…
VIDEO SHOWS: REAL MADRID HOLDING TRAINING SESSION AND COACH JOSE MOURINHO HOLDING PRESS CONFERENCE AHEAD…
TOP HOUSE FINANCIAL SERVICES DEMOCRAT MAXINE WATERS CALLS ON LAWMAKERS TO RETURN HER TO COMMITTEE…